Clinical Trial Update: Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites [Phase 1, Phase 2]

View source ↗

Summary

Renovo's Juvidex (mannose-6-phosphate) trial for accelerating healing of split-thickness skin graft donor sites has completed Phase 1/Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wound

Drugs mentioned

• Juvidex (Mannose-6-Phosphate)

Snippet

Sponsor: Renovo | Conditions: Wound | Phase 1, Phase 2 | Status: COMPLETED